Keratinocyte Growth Factor to Prevent Acute GVHD

NCT00031148 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

72

Enrollment

FED

Sponsor class

Conditions

Graft-vs-Host Disease

Interventions

DRUG: Recombinant Human Keratinocyte Growth Factor (rHuKGF)

Sponsor

FDA Office of Orphan Products Development